B

Boundless Bio Inc
NASDAQ:BOLD

Watchlist Manager
Boundless Bio Inc
NASDAQ:BOLD
Watchlist
Price: 3.24 USD -9.24% Market Closed
Market Cap: 72.1m USD
Have any thoughts about
Boundless Bio Inc?
Write Note

Boundless Bio Inc
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Boundless Bio Inc
Capital Expenditures Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
B
Boundless Bio Inc
NASDAQ:BOLD
Capital Expenditures
-$633k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Capital Expenditures
-$888m
CAGR 3-Years
0%
CAGR 5-Years
-12%
CAGR 10-Years
-4%
Gilead Sciences Inc
NASDAQ:GILD
Capital Expenditures
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Capital Expenditures
-$974m
CAGR 3-Years
-8%
CAGR 5-Years
-8%
CAGR 10-Years
-1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Capital Expenditures
-$481.8m
CAGR 3-Years
-30%
CAGR 5-Years
-45%
CAGR 10-Years
-25%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Capital Expenditures
-$928.1m
CAGR 3-Years
-18%
CAGR 5-Years
-20%
CAGR 10-Years
-13%

See Also

What is Boundless Bio Inc's Capital Expenditures?
Capital Expenditures
-633k USD

Based on the financial report for Dec 31, 2023, Boundless Bio Inc's Capital Expenditures amounts to -633k USD.

What is Boundless Bio Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 1Y
41%

Over the last year, the Capital Expenditures growth was 41%.

Back to Top